Thrombosis in cancer patients: Etiology, incidence, and management

Rahul A. Sheth, Andrew Niekamp, Keith B. Quencer, Fadi Shamoun, Grace Knuttinen, Sailendra Naidu, Rahmi Oklu

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Venous thromboembolism (VTE) is the second most common cause of mortality in cancer patients. The mechanisms of cancer-associated thrombosis (CAT), much like cancer itself, are multi-factorial and incompletely understood. Cancer type, stage, tumor-derived factors and genetics all affect CAT risk. Furthermore, cancer therapies as well as the indwelling vascular devices through which these therapies are delivered can increase the risk for CAT. In this review, we summarize mechanisms of hypercoagulability in cancer patients, patterns of thrombosis associated with cancer, current guidelines for the diagnosis and management of CAT, and important considerations regarding the placement of implantable vascular devices in the care of cancer patients with VTE.

Original languageEnglish (US)
Pages (from-to)S178-S185
JournalCardiovascular Diagnosis and Therapy
Volume7
DOIs
StatePublished - Dec 1 2017

Fingerprint

Thrombosis
Incidence
Neoplasms
Venous Thromboembolism
Blood Vessels
Equipment and Supplies
Thrombophilia
Patient Care
Guidelines
Mortality
Therapeutics

Keywords

  • Anticoagulation
  • Cancer
  • Venous access catheters
  • Venous thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Thrombosis in cancer patients : Etiology, incidence, and management. / Sheth, Rahul A.; Niekamp, Andrew; Quencer, Keith B.; Shamoun, Fadi; Knuttinen, Grace; Naidu, Sailendra; Oklu, Rahmi.

In: Cardiovascular Diagnosis and Therapy, Vol. 7, 01.12.2017, p. S178-S185.

Research output: Contribution to journalReview article

Sheth, Rahul A. ; Niekamp, Andrew ; Quencer, Keith B. ; Shamoun, Fadi ; Knuttinen, Grace ; Naidu, Sailendra ; Oklu, Rahmi. / Thrombosis in cancer patients : Etiology, incidence, and management. In: Cardiovascular Diagnosis and Therapy. 2017 ; Vol. 7. pp. S178-S185.
@article{a1450852e4264136beb1bc65d18d4378,
title = "Thrombosis in cancer patients: Etiology, incidence, and management",
abstract = "Venous thromboembolism (VTE) is the second most common cause of mortality in cancer patients. The mechanisms of cancer-associated thrombosis (CAT), much like cancer itself, are multi-factorial and incompletely understood. Cancer type, stage, tumor-derived factors and genetics all affect CAT risk. Furthermore, cancer therapies as well as the indwelling vascular devices through which these therapies are delivered can increase the risk for CAT. In this review, we summarize mechanisms of hypercoagulability in cancer patients, patterns of thrombosis associated with cancer, current guidelines for the diagnosis and management of CAT, and important considerations regarding the placement of implantable vascular devices in the care of cancer patients with VTE.",
keywords = "Anticoagulation, Cancer, Venous access catheters, Venous thrombosis",
author = "Sheth, {Rahul A.} and Andrew Niekamp and Quencer, {Keith B.} and Fadi Shamoun and Grace Knuttinen and Sailendra Naidu and Rahmi Oklu",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/cdt.2017.11.02",
language = "English (US)",
volume = "7",
pages = "S178--S185",
journal = "Cardiovascular Diagnosis and Therapy",
issn = "2223-3652",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Thrombosis in cancer patients

T2 - Etiology, incidence, and management

AU - Sheth, Rahul A.

AU - Niekamp, Andrew

AU - Quencer, Keith B.

AU - Shamoun, Fadi

AU - Knuttinen, Grace

AU - Naidu, Sailendra

AU - Oklu, Rahmi

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Venous thromboembolism (VTE) is the second most common cause of mortality in cancer patients. The mechanisms of cancer-associated thrombosis (CAT), much like cancer itself, are multi-factorial and incompletely understood. Cancer type, stage, tumor-derived factors and genetics all affect CAT risk. Furthermore, cancer therapies as well as the indwelling vascular devices through which these therapies are delivered can increase the risk for CAT. In this review, we summarize mechanisms of hypercoagulability in cancer patients, patterns of thrombosis associated with cancer, current guidelines for the diagnosis and management of CAT, and important considerations regarding the placement of implantable vascular devices in the care of cancer patients with VTE.

AB - Venous thromboembolism (VTE) is the second most common cause of mortality in cancer patients. The mechanisms of cancer-associated thrombosis (CAT), much like cancer itself, are multi-factorial and incompletely understood. Cancer type, stage, tumor-derived factors and genetics all affect CAT risk. Furthermore, cancer therapies as well as the indwelling vascular devices through which these therapies are delivered can increase the risk for CAT. In this review, we summarize mechanisms of hypercoagulability in cancer patients, patterns of thrombosis associated with cancer, current guidelines for the diagnosis and management of CAT, and important considerations regarding the placement of implantable vascular devices in the care of cancer patients with VTE.

KW - Anticoagulation

KW - Cancer

KW - Venous access catheters

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85038629405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038629405&partnerID=8YFLogxK

U2 - 10.21037/cdt.2017.11.02

DO - 10.21037/cdt.2017.11.02

M3 - Review article

AN - SCOPUS:85038629405

VL - 7

SP - S178-S185

JO - Cardiovascular Diagnosis and Therapy

JF - Cardiovascular Diagnosis and Therapy

SN - 2223-3652

ER -